STTK
Shattuck Labs Inc.
$7.40
$0.00(0.00%)
61
Overall
60
Value
81
Tech
44
Quality
Market Cap
$485.21M
Volume
987.53K
52W Range
$0.69 - $6.81
Target Price
$10.00
Company Overview
| Mkt Cap | $485.21M | Price | $7.40 |
| Volume | 987.53K | Change | +0.00% |
| P/E Ratio | -6.4 | Open | $7.02 |
| Revenue | $5.7M | Prev Close | $7.40 |
| Net Income | $-75.4M | 52W Range | $0.69 - $6.81 |
| Div Yield | N/A | Target | $10.00 |
| Overall | 61 | Value | 60 |
| Quality | 44 | Technical | 81 |
No chart data available
About Shattuck Labs Inc.
Shattuck Labs, Inc., a biotechnology company, develops antibodies for the treatment of inflammatory and immune-mediated diseases. The company's lead product candidate is SL-325, a monoclonal antibody which activates immune responses through binding a single receptor, DR3; and SL-425. It also develops multiple preclinical DR3-based bispecific antibodies for the treatment of inflammatory bowel disease. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.
Sector: Industrials
Industry: Pharmaceutical Preparation Manufacturing
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | STTK | $7.40 | 0% | 987.53K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |